Author

Baba Inusa

paediatric haematology - Cited by 3,544 - sickle cell disease - thalassaemia - iron overload

Biography

Baba Inusa is a Consultant (Paediatrics and Haematology) at Guy's and Saint Thomas' NHS Foundation Trust: London, United Kingdom. Along with that he is serving as a Professor (Paediatric haematology) King's College School: London, United Kingdom.
Title
Cited by
Year
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia
DC Rees, Y Kilinc, S Unal, C Dampier, BS Pace, B Kaya, S Trompeter, ...Blood, The Journal of the American Society of Hematology 139 (), 2642-2652, 2022202
17
2022
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years
JH Estepp, R Kalpatthi, G Woods, S Trompeter, RI Liem, K Sims, A Inati, ...Pediatric blood & cancer 69 (8), e297, 2022202
16
2022
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study
JL Kwiatkowski, M Hamdy, A El-Beshlawy, FSE Ebeid, M Badr, A Alshehri, ...Blood Advances 6 (4), 1243-1254, 2022202
14
2022
Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
MS Elalfy, M Hamdy, A El-Beshlawy, FSE Ebeid, M Badr, J Kanter, ...Blood Advances (4), 611-619, 2023202
7
2023
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
MM Heeney, MR Abboud, J Githanga, BPD Inusa, J Kanter, AD Michelson, ...Blood, The Journal of the American Society of Hematology 140 (13), 1470-1481, 2022202
6
2022
Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia
H Stotesbury, PW Hales, M Koelbel, AM Hood, JM Kawadler, ...Journal of Cerebral Blood Flow & Metabolism 42 (), 101-1077, 2022202
6
2022
Individual watershed areas in sickle cell anemia: an arterial spin labeling study
H Stotesbury, PW Hales, AM Hood, M Koelbel, JM Kawadler, ...Frontiers in Physiology 13, 85391, 2022202
6
2022
The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology
NS Green, A Zapfel, OE Nnodu, P Franklin, VN Tubman, L Chirande, ...Blood Advances (24), 187-197, 2022202
6
2022
Quantification of silent cerebral infarction on high-resolution FLAIR and cognition in sickle cell anemia
H Stotesbury, JM Kawadler, JD Clayden, DE Saunders, AM Hood, ...Frontiers in Neurology 13, 867329, 2022202
5
2022
A qualitative exploration of health-related quality of life and health behaviours in children with sickle cell disease and healthy siblings
C Constantinou, N Payne, O van den Akker, B InusaPsychology & Health 38 (1), 12-146, 2023202
5
2023
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort
C Strunk, I Tartaglione, CM Piccone, R Colombatti, B Andemariam, ...Blood Cells, Molecules, and Diseases 92, 102612, 2021202
4
2021
Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries
NM Archer, B Inusa, J Makani, S Nkya, L Tshilolo, VN Tubman, ...BMJ open 12 (3), e057623, 2022202
4
2022
Lung clearance index may detect early peripheral lung disease in sickle cell Anemia
M Arigliani, FJ Kirkham, S Sahota, M Riley, I Liguoro, L Castriotta, A Gupta, ...Annals of the American Thoracic Society 19 (9), 1507-1515, 0
2
2022
Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trial
AM Hood, H Stotesbury, M Kölbel, M DeHaan, M Downes, JM Kawadler, ...Trials , 1-18, 010
2
2021
Deep learning-based quality-controlled spleen assessment from ultrasound images
Z Yuan, E Puyol-Antón, H Jogeesvaran, N Smith, B Inusa, AP KingBiomedical Signal Processing and Control 76, 10374, 0
2
2022
S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND …
S20: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND …B Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, ...Hemasphere 6, 0-, 2022202
1
2022
S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
S5: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIASB Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, ...Hemasphere 6, 8, 2022202
1
2022
The impact of urbanization and wealth on house dust mite sensitization in children from north-central Nigeria
C Zuiani, M Arigliani, R Zubair, LG Dogara, L Castriotta, AD Sunday, ...Italian Journal of Pediatrics 48 (), -4, 2022202
1
2022